Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Carroll

Showing results (121-130 of 192) with videos related to

Pageof 20
Sort By:
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Oncogene|January 26, 2018
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancerAlacoque L Browne, Sara Charmsaz, Damir Varešlija, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Cancer Research|July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerThomas W Owens, Renee L Rogers, Sarah Best, et al.
Cell Reports|July 5, 2023
FOXA2 controls the anti-oxidant response in FH-deficient cellsConnor Rogerson, Marco Sciacovelli, Lucas A Maddalena, et al.
Chemical Communications (Cambridge, England)|January 19, 2022
Divinylpyrimidine reagents generate antibody-drug conjugates with excellent <i>in vivo</i> efficacy and tolerabilityStephen J Walsh, Soleilmane Omarjee, Friederike M Dannheim, et al.
Cell|July 13, 2005
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1Jason S Carroll, X Shirley Liu, Alexander S Brodsky, et al.
Molecular Cancer Therapeutics|February 28, 2018
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast CancerChrysiis Michaloglou, Claire Crafter, Rasmus Siersbaek, et al.
Cancer Research|August 7, 2016
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17Dong G Hu, Luke A Selth, Gerard A Tarulli, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Pageof 20

Showing results (121-130 of 192) with videos related to

Sort By:
Pageof 20
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Oncogene|January 26, 2018
Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancerAlacoque L Browne, Sara Charmsaz, Damir Varešlija, et al.
Molecular and Cellular Endocrinology|November 28, 2016
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Arnoud J Groen, Jodi L Miller, et al.
Cancer Research|July 25, 2014
Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerThomas W Owens, Renee L Rogers, Sarah Best, et al.
Cell Reports|July 5, 2023
FOXA2 controls the anti-oxidant response in FH-deficient cellsConnor Rogerson, Marco Sciacovelli, Lucas A Maddalena, et al.
Chemical Communications (Cambridge, England)|January 19, 2022
Divinylpyrimidine reagents generate antibody-drug conjugates with excellent <i>in vivo</i> efficacy and tolerabilityStephen J Walsh, Soleilmane Omarjee, Friederike M Dannheim, et al.
Cell|July 13, 2005
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1Jason S Carroll, X Shirley Liu, Alexander S Brodsky, et al.
Molecular Cancer Therapeutics|February 28, 2018
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast CancerChrysiis Michaloglou, Claire Crafter, Rasmus Siersbaek, et al.
Cancer Research|August 7, 2016
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17Dong G Hu, Luke A Selth, Gerard A Tarulli, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Pageof 20